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1. Current malaria 
epidemiology
A detailed understanding of an infectious agent’s 
epidemiology is essential for effectively targeting disease 
control and elimination measures.[1] Accordingly, locally 
specific epidemiological understanding is pivotal to the success of 
malaria elimination in South Africa (SA). 
2. Morbidity and mortality 
Malaria is endemic in northeastern areas of KwaZulu-Natal (KZN), 
Mpumalanga and Limpopo provinces. As a result of sustained vector 
control and case management, annual cases were sustained below 
10  000 for many years, with approximately 8  750 notified cases in 
1995. With decreased insecticide and treatment efficacy, malaria 
cases and deaths increased sharply from 1996, peaking in 2000. In 
1996 malaria cases increased by 67% compared with the previous 
year, rising to over 60 000 cases in 2000 when more than 400 deaths 
were recorded (Fig. 1). The loss of sulphadoxine-pyrimethamine 
(SP) efficacy may have contributed to the huge increase in deaths 
during this time period. Following the introduction of an effective 
insecticide, artemisinin-containing combination treatment (ACT) 
and the adoption of regional malaria control strategies in SA, 
Swaziland and Mozambique, national case numbers decreased to 
26 506 in 2001 and continued to decrease to <10 000 by 2011 (Fig. 1).
2.1 Morbidity and mortality in the provinces
Over the 10-year study period, the total number of reported malaria 
cases decreased markedly from 64  622 in 2000 to 8  066 in 2010 
(Fig. 2). The largest decrease was noted in KZN, with this province 
reporting the lowest number of cases in 2010 (Fig. 2). Although 
case numbers in Limpopo declined from 9 487 in 2000 to 4 215 in 
2010, this province has become the largest contributor to malaria 
incidence of the three endemic provinces (Fig. 2). Similar to malaria 
case numbers, malaria-related mortality decreased during the study 
period, from 459 deaths in 2000 to 87 deaths in 2010 (Fig. 2). 
Again, the province associated with the greatest decline in malaria-
associated deaths was KZN, while the highest number of deaths in 
2010 was reported in Limpopo (Fig. 2).
3.  Factors favouring malaria 
transmission
3.1 Parasitology and drug resistance
The causative agent in over 90% of the malaria infections in SA 
has been and remains Plasmodium falciparum. Although extremely 
virulent, P. falciparum malaria infection rates were suppressed by 
effective control measures until the early 1980s.[2,3] SA implemented 
a monitoring system to regularly review the in vitro effectiveness of 
first-line treatment and interpret the potential contribution of drug 
resistance to changing trends in malaria incidence. This approach has 
ensured the availability of good quality data to facilitate evidence-
based decision-making on drug treatment. 
Between 1980 and 1987, case numbers and chloroquine treatment 
failures in KZN Province increased sharply, principally due to the 
emergence of chloroquine-resistant parasites,[4] prompting a drug 
policy change. SP replaced chloroquine as first-line treatment in the 
province in 1998, initially resulting in a decline in case numbers. 
Unfortunately, the development of SP-resistant parasites[5,6] led to an 
increase in malaria case numbers which peaked during the 1999/2000 
malaria season in KZN.[7] The deployment of ACT, using artemether-
lumefantrine, in 2001 ensured a dramatic decline in malaria cases 
numbers, which has been sustained.[8]
Parasites in both Mpumalanga and Limpopo provinces remained 
susceptible to chloroquine until the mid- to late-1990s. In response to 
increasing numbers of chloroquine-resistant parasites, SP became the 
antimalarial of choice in Mpumalanga Province in 1997 and Limpopo 
Province in 1998.[2] SP remained efficacious in these provinces 
for over 12 years before increases in both SP treatment failures 
and parasites carrying SP resistance markers were detected. [9-11] 
Artemether-lumefantrine became the drug of choice in both these 
provinces in 2003.[12] Currently P. falciparum parasites in SA appear 
to be susceptible to artemisinin derivatives and most of their partner 
drugs.
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3.2 Entomology
The predominant malaria vectors in SA belong 
to the Anopheles gambiae and An. funestus 
complexes. Within the An. gambiae complex, 
only An. gambiae sensu stricto, An. arabiensis 
and An.  merus have been implicated in local 
malaria transmission. An.  gambiae  s.s was 
eliminated from SA in the late 1960s and An. 
merus has previously only played a minor role 
in malaria transmission. An. arabiensis is thus 
the primary SA malaria vector.
An. funestus funestus is the only member of 
the An. funestus complex to be implicated in 
local malaria transmission and it was reported 
to be eliminated in 1974; however, it re-emerged 
in KZN in 1999 and was found to be resistant 
to the pyrethroid insecticide used for malaria 
control in that province. The reintroduction 
of dichlorodiphenyltrichloroethane (DDT) in 
2000 resulted in this vector once again being 
eliminated from SA.
The entomology of malaria mosquitoes in 
SA has been well characterised.[13] An. arabiensis 
is zoophilic, readily feeding on cattle or 
humans and is both endo- and exophagic. 
It has modified its behaviour to be mostly 
exophilic. Recently, An. merus mosquitoes have 
been found in increasing abundance and could 
become an increasingly important vector.[13]
3.3 Climatology
Climate imposes distinct biological 
constraints on the malaria parasite and 
anopheline mosquito development and 
survival. Low temperatures slow the time to 
sporogony in the insect thereby reducing the 
probability of infectious mosquito survival. 
Low rainfall severely restricts potential vector 
breeding sites, with a major impact on vector 
abundance and vectorial capacity. [1] These 
climatic factors have restricted the area of 
SA suitable for malaria transmission to the 
southern periphery of the continent’s malaria-
endemic zone.[14] The temperate climate 
dictates that malaria occurrence is seasonal, 
restricted to the summer months when 
temperatures are ideal for vector survival. 
Climate also affects inter-annual malaria 
case fluctuation, although this has been 
enormously tempered in recent years by 
the effective malaria prevention and control 
programme. Studies of the relationship 
between malaria transmission intensity 
and climatic factors have served to explain, 
predict and forecast the distribution and 
the case numbers in different locations 
at different times. Malaria incidence 
is significantly synchronised with the El 
Niño Southern Oscillation, with below 
average incidence during El Niño years and 
above average incidence during El Niña 
years.[15] Modelling found that inter-annual 
incidence variation is driven by climatic 
factors. Temperature and rainfall were good 
predictors of incidence in a 30-year analysis 
of KZN data,[3] and variation in rainfall 
was significantly correlated with annual 
malaria incidence rates in Mpumalanga 
Province. [16] In KZN, spatial heterogeneity in 
local malaria incidence was partly explained 
by differences in average local rainfall and 
temperature.[17] The multi-factorial nature of 
malaria transmission has resulted in climatic 
models only having limited success in 
producing long and medium range forecasts 
of malaria case numbers and distribution.[18]
4.  Social and economic 
aspects of malaria
Malaria has serious economic impacts 
in Africa, slowing economic growth and 
development and perpetuating the cycle 
of poverty. Malaria epitomises a disease of 
poverty, affecting primarily the poor who are 
resident in malaria-prone rural areas with 
poorly-constructed dwellings that offer few 
barriers against mosquitoes. The global and 
African distributions of malaria and poverty 
are sympatric. Limited formal education, 
poor engineering and construction, and 
inaccessibility of healthcare, contribute to 
increase malaria risk in impoverished rural 
populations. Community beliefs can affect 
control, with opposition to indoor spraying, or 
early treatment seeking, with delays occasioned 
by initial care provided by traditional healers.
During periods when malaria control was 
inadequate in SA, it posed a considerable 
burden on the economy of affected provinces 
through lost productivity, reduced tourism, 
and direct expenditure on healthcare 
provision and control programme delivery. 
5.  Impact of case 
management with the 
rational use of drugs 
and rapid diagnostic 
tests
Comprehensive systematic reviews of 
all malaria deaths in two SA provinces, 
Mpumalanga and Limpopo, demonstrated 
that delays in malaria diagnosis and initiating 
appropriate therapy were key contributors 
to preventable malaria deaths.[19] Failed 
first-line malaria therapy and health 
system weaknesses, particularly in ensuring 
availability of appropriate antimalarial drugs 
were implicated in avoidable treatment 
delay. Malaria epidemiology in SA has been 
revolutionised by the availability of prompt 
accurate diagnosis, particularly through 
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Fig. 2. Number of malaria cases and malaria deaths by year and malaria-endemic province.
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Fig. 1. Malaria cases and deaths reported in South Africa, 1995 - 2011 (source: Malaria Research Unit, 
Medical Research Council).
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programme-wide implementation of rapid diagnostic tests (RDTs). 
Similarly assured access to therapy, demonstrated to be effective 
against locally circulating parasites, has been a key determinant 
of epidemiological trends. These factors influence the scale of the 
parasite reservoir, impact on absolute case numbers, confound the 
interpretation of epidemiological trends and have a detrimental 
impact on disease outcomes.
6. Timely diagnosis
There is an established precedent of confirming all malaria diagnoses 
in SA, rather than relying on clinical signs alone. Historically, 
malaria diagnosis in the malaria-endemic provinces relied upon the 
examination of blood smears. This resulted in delays in diagnosis 
and the quality of microscopy was enormously variable with poor 
diagnostic concordance found between diagnostic services.[20] Delays 
in diagnosis contributed to higher case fatality ratios[19] and treatment 
delays which resulted in increased gametocytes thereby contributing 
to higher transmission potential. 
The field testing of immunochromatographic RDTs for malaria 
diagnosis in Mpumalanga Province provided compelling evidence 
of their high sensitivity and specificity during field use by clinical 
and malaria field staff.[21,22] Their utility, accuracy and reliability, 
resulted in broad implementation as the first-line diagnostic method 
throughout malaria-endemic areas.[22]
This introduction of RDTs at programme level was a first in Africa; 
until this point, RDTs had only been used in small-scale field trials. 
The reliable programme availability of RDTs was confirmed during 
the 1998 and 2009 national malaria reviews.
7. Drug stock-outs 
Having an effective antimalarial drug on the formulary is necessary, 
but it is equally important that health staff are well educated on its 
correct use, that they rapidly initiate treatment and that the health 
system ensures its availability at all treatment sites.[23] Community 
members need to trust the drug and health system reliability or 
they may seek alternative and often ineffective malaria treatment 
elsewhere, including traditional healers, resulting in higher rates 
of complicated disease and poor outcomes.[24] Stock-outs of vital 
antimalarials result in increased malaria transmission with higher 
case numbers, and most importantly, disease progression with severe 
malaria. 
A detailed study of antimalarial drug management, supply and 
use was conducted in KZN and Mpumalanga provinces.[25] This study 
found common deficiencies in inventory control systems, with the risk 
of shrinkage and spoilage. Although standard treatment guidelines 
and regular training were implemented in the public sector, this was 
variable in the private sector. Exit interviews with patients indicated 
that there was scope for improving treatment information being 
provided. Patients had great trust in public sector clinics for malaria 
treatment; thus, drug supply systems must continually be assured. It 
was encouraging to note that the 2009 national malaria programme 
review found that stock-outs were uncommon.
8.  Monitoring, evaluation and 
surveillance
Active and passive case reports are fed into provincial desktop 
malaria information systems (MIS) and then integrated nationally 
using a web-based platform. Cases diagnosed in clinics or hospitals 
are entered in registers and reported to district offices weekly. Details 
of cases diagnosed by RDT or microscopy by programme field staff 
are entered into the provincial MIS. This allows the automated or 
customised generation of aggregate daily, weekly, monthly, annual 
or seasonal reports at facility, locality, municipality (sub-district), 
district or provincial level. These data facilitate detailed planning and 
review at provincial level, and monitoring at national level. Ongoing 
system maintenance, data flow and quality control are affected at 
provincial level with national support.
Indoor residual spraying (IRS) activity is recorded on field 
data cards, summarised by field managers and then entered into 
the electronic data-management system. Captured data include 
number of structures sprayed, type and quantity of insecticide 
used, and locality of spraying. The electronic system generates 
routine spraying coverage rates, insecticide use, spray personnel 
activity and application rates. These reports assist the planning of 
resource deployment and timing, and support management through 
monitoring progress. Spatial decision support allows malaria case 
mapping at district, sub-district, locality and facility levels to enable 
interpretation of spatial disease patterns. Mpumalanga Province also 
maps the source of infection.
9. Vector control
The mainstay of vector control is IRS application to the inner walls 
of houses once or twice a year. Frequency depends on the insecticide 
used, with different chemicals used for traditional mud and thatch 
buildings and Western type structures. Over the past seventy years, 
IRS has been a critical factor in decreasing disease burden to levels 
that make elimination possible.
10. Insecticide resistance
An important challenge for successful vector control is the 
development of insecticide resistance in vectors. It appears that 
local resistance is restricted to pyrethroids in An. funestus. Isolated 
populations of An. arabiensis previously found to be resistant to DDT 
were eliminated using carbamates. An. arabiensis in SA is currently 
susceptible to all classes of insecticides. As current field research 
in this area is limited, there is a risk of surreptitious evolution of 
resistance without detection.
11. Cross-border malaria initiatives
SA shares borders with countries that have high malaria transmission 
burdens and poor malaria control. The potential exists for importation 
of insecticide resistant mosquitoes and/or drug resistant parasites 
that can cause focal outbreaks.
The Lubombo Spatial Development Initiative (LSDI) was 
an effective initiative between Mozambique, SA and Swaziland 
established to tackle high malaria incidence in northern KZN 
Province, eastern Swaziland and southern Mozambique. The malaria 
control interventions already existing in SA and Swaziland were 
strengthened, while simultaneously introducing integrated control 
in southern Mozambique. After five years the LSDI strategy had 
resulted in a decrease in malaria incidence of 99% in KZN, 98% in 
Swaziland and 92% in Maputo Province, Mozambique, compared 
with baseline levels in 2000.[26]
Collaborative international efforts could also potentially extend 
the effective life of insecticides and drugs, by co-ordinating policy 
efforts.
12. Population migration
The high-volume migrancy across SA’s northern and eastern land 
borders places a continuing risk to non-immune border populations. 
Previous efforts to screen and treat malaria at ports of entry were 
thwarted by malaria smear turn-around times and informal border 
crossings and raises sensitivities around treatment strategies towards 
migrant populations. 
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Between January and December 2011, 64% 
(n=6 324) of all malaria cases reported were 
imported (Table 1), with 85% of cases in 
Gauteng, KZN and Mpumalanga originating 
in Mozambique. Thirty percent of imported 
cases in Limpopo, where the source was 
known, were from Mozambique, and 53% 
were from Zimbabwe. In areas receptive to 
malaria, where malaria vectors are present, 
imported malaria can contribute to local 
transmission.[7]
13. Malaria epidemics
Malaria epidemics are ‘an acute exacerbation 
of disease out of proportion to the normal to 
which the community is subject’. Epidemics 
are common only in zones of unstable 
malaria, where very slight modification 
in any of the transmission factors may 
completely upset equilibrium, and where the 
restraining influence of immunity may be 
negligible or absent, and they therefore show 
a very marked geographic distribution.[1]
Malaria-prone areas of SA meet all these 
criteria, and have experienced epidemics. 
The ‘restraining influence of immunity’ is 
largely absent in the local population, and 
climatic factors are sufficiently variable to 
cause substantial interannual variation in 
malaria incidence.[3] Comprehensive malaria 
prevention through IRS and effective treatment 
with ACT has exerted another powerful 
‘restraining influence’ on malaria epidemics 
in SA.[2] Malaria epidemics thus reflect the 
interplay between partial or complete failure of 
malaria control measures and extreme weather 
conditions. The KZN epidemic of 1999/2000 
provides an example of the effect of twin 
failures of IRS vector control due to pyrethroid 
resistance in An.  funestus,[27] and first-line 
antimalarial drug resistance.[28] Once DDT 
was re-introduced for IRS and artemether-
lumefantrine as first-line therapy, the epidemic 
was quickly controlled with malaria-related 
outpatient cases and hospital admissions 
falling by 99% in subsequent years.[8]
14. Current challenges
14.1  Malaria elimination status 
of the provinces
All 3 malaria-endemic provinces are at 
different phases within the malaria elimination 
continuum (Fig. 3).
In KZN, all districts have a malaria case 
incidence of <1/1  000 population at risk; 
therefore, this province as a whole meets the 
World Health Organization (WHO) criteria 
to move from control to elimination phases. 
Although the malaria transmission areas in 
Mpumalanga have decreased greatly, two 
municipalities within the Ehlanzeni District 
(Fig. 3) have malaria incidences that exceed 
the elimination phase threshold. One area 
remains in the control phase while the second 
falls into the pre-elimination category (Fig. 3). 
The incidence of malaria in Limpopo has not 
changed much over the study period (Fig. 3). 
The high-risk area in Vhembe District has 
changed minimally since the 1999/2000 
season and remains in the control phase. 
According to the 1999/2000 malaria incidence 
map, 2/5 municipalities in Mopani District 
were in the pre-elimination phase, one was 
in the control phase while the remaining 
two areas were already in the elimination 
phase. In the 2010/2011 map, the two areas 
in the elimination phase remain unchanged, 
while the area in the control phase has been 
elevated to pre-elimination status with one of 
the 1999/2000 pre-elimination areas gaining 
an elimination rating.
As a result of these variances in the status 
of the malaria-affected districts, uniform 
measures cannot be implemented across the 
malaria-affected provinces. This poses an 
additional challenge in that some districts 
are further advanced than others. The 
elimination agenda cannot be scaled up until 
all districts reach the elimination phase.
14.2  Migrating the malaria 
information system
The MIS is currently used in the three 
malaria-endemic provinces in SA. Data are 
uploaded weekly by the information officer to 
a central server housed at the South African 
Medical Research Council in Durban. Data 
are further verified by the staff in the database 
section before a web-based data (Malaria Data 
Management System (MDMS)) warehouse is 
updated with the latest datasets. The MDMS 
utilises business intelligence technology to 
deliver the data in various reporting formats 
that are used by various staff and researchers 
in the South African malaria community. 
14.3  Policies to support malaria 
elimination 
It is widely accepted that malaria control 
and elimination programmes should be 
owned and led by governments. Appropriate 
policies need to be in place to cover the 
wide range of activities required for malaria 
elimination. These policies also need to be 
supported with the appropriate financial 
resources. Moreover, when capacities within 
governments are not adequate to serve the 
needs of a malaria elimination programme, 
then space must be created to allow non-
governmental organisations, research and 
academia to come on board.
SA has been successful in ensuring 
that key commodities are in place and 
distributed to facilities (e.g. RDTs, drugs and 
insecticides) and that vector control teams 
are in place. SA faces its biggest challenge for 
Table 1. Imported and local malaria cases reported in KwaZulu-Natal, Limpopo and 
Mpumalanga provinces, South Africa (2005 - 2011)
Cases, %
Province Malaria season (year) Local Imported Unclassified
KwaZulu-Natal 2005/2006 30 41 29
2006/2007 20 46 35
2007/2008 14 52 34
2008/2009 11 47 41
2009/2010 11 42 48
2010/2011 19 50 31
Limpopo 2005/2006 60 13 27
2006/2007 71 14 15
2007/2008 73 10 17
2008/2009 52 14 34
2009/2010 62 15 23
2010/2011 57 18 24
Mpumalanga 2005/2006 31 60 9
2006/2007 32 68 0
2007/2008 30 70 0
2008/2009 25 75 0
2009/2010 28 72 0
2010/2011 20 80 0
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elimination from the importation of malaria 
from its neighbouring countries, and polices 
and processes need to be in place to ensure 
cross-border collaboration and sharing of 
resources to enable optimal malaria coverage 
within SA and its neighbours. 
The relationships between malaria 
elimination and health systems strengthening 
require further exploration in the SA context. 
In addition, the value and engagement with 
non-governmental healthcare providers, 
and outsourcing of malaria elimination 
functions, also needs to be considered. 
The essential role of full participation and 
engagement by communities is also required. 
15.  Transitioning to 
elimination
For SA the key challenges for moving the 
malaria elimination agenda, specifically on 
surveillance, are: transmission districts and 
localities that are still in the control phase of 
the WHO’s malaria elimination continuum; 
data quality and efficiency of data flows 
from peripheral to central levels; limited 
entomological surveillance to determining 
malaria hotspots; close proximity of the 
moderate-and high-transmission districts, 
and location in relation to neighbouring 
countries that have relatively higher burdens of 
malaria transmission; and regular monitoring 
for insecticide and drug resistance. 
In SA the mainstay of the control programmes 
is indoor spraying with a residual insecticide. 
This has been in place for the past 70 years 
and the only variable that has changed is 
the insecticide used. Alternative and 
complementary measures are now required 
to help get to zero cases.
16. Conclusion
The incidence of malaria mortality and 
morbidity has declined remarkably over the 
past 12 years to such an extent that malaria 
elimination is now possible in KZN and some 
districts of Limpopo and Mpumalanga. There 
are a number of variables that drive transmission 
in SA that enhance the relationship between 
the host, vector and parasite. However, due to 
sustained malaria vector control and improved 
case management, the number of local cases 
has declined dramatically, an equilibrium has 
been reached, and the reorientation of the 
malaria control programme to an elimination 
one will assist in achieving zero locally-
transmitted cases. 
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Fig. 3. Phase of malaria elimination continuum per district in KwaZulu-Natal, Limpopo and 
Mpumalanga provinces, South Africa (1999/2000 and 2010/2011 malaria seasons).
